kabutan

Delta-Fly Pharma, Inc.(4598) Summary

4598
TSE Growth
Delta-Fly Pharma, Inc.
546
JPY
-61
(-10.05%)
Dec 12, 3:30 pm JST
3.50
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
549.9
Dec 12, 11:58 pm JST
Summary Chart Historical News Financial Result
PER
PBR
18.3
Yield
ー%
Margin Trading Ratio
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
599 JPY 3.85 USD
Previous Close Dec 11
607 JPY 3.88 USD
High Dec 12, 9:02 am
620 JPY 3.98 USD
Low Dec 12, 12:34 pm
531 JPY 3.41 USD
Volume
2,023,400
Trading Value
1.13B JPY 7.28M USD
VWAP
560.28 JPY 3.6 USD
Minimum Trading Value
54,600 JPY 350 USD
Market Cap
6.43B JPY 0.04B USD
Number of Trades
3,274
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
Slightly High
1-Year Average
944
1-Year High Dec 10, 2025
15,787
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 0 2,034,300
Nov 28, 2025 600 2,068,700 3447.83
Nov 21, 2025 0 2,140,400
Nov 14, 2025 900 2,115,000 2350.00
Nov 7, 2025 1,600 1,853,100 1158.19
Company Profile
Delta-Fly Pharma, Inc. is a bioventure company developing anticancer drugs. The company handles everything from research and development to manufacturing and sales.
Sector
Pharmaceuticals
Delta-Fly Pharma, Inc. is a bioventure company that consistently handles the entire process from research and development to manufacturing and sales of anticancer drugs. Using its proprietary "modular drug discovery" method, the company aims to create new anticancer drugs with an excellent balance of clinical efficacy and safety by combining existing anticancer active substances. With multiple development pipelines, the company is conducting clinical trials targeting recurrent and refractory acute myeloid leukemia, lung cancer, pancreatic cancer, and other conditions. Their business model is based on generating revenue through product sales, milestone payments, and royalty income by out-licensing sales rights to pharmaceutical companies. Focusing on licensing agreements with pharmaceutical companies, Delta-Fly Pharma has established an efficient research and development system by utilizing external resources.